This website uses cookies.
By continuing to use this website, you consent to our use of these cookies. Read more about our use of cookies
Joint damage and QoL for PwH
Joint damage can have a profound effect on patients’ quality of life1,2
Joint bleeds have been reported to account for up to 90% of serious bleeding events in patients3
Over time, complications from recurrent haemarthrosis can result in severe arthropathy, leading to chronic pain, disability and impairment of health-related quality of life1,4
Life-long joint arthropathy and pain should not be the accepted norm of a haemophilia diagnosis. Isn’t it time to give your patients a fresh perspective on life?
PwH, people with haemophilia; Qol, quality of life; rFVIII, recombinant Factor VIII.
References
1. Knobe K, Berntorp E. Haemophilia and joint disease: pathophysiology, evaluation, and management. J Comorb. 2011 Dec;1:51–9.
2. Wyseure T, Mosnier LO, von Drygalski A. Advances and Challenges in Hemophilic Arthropathy. Semin Hematol. 2016 Jan;53(1):10–9.
3. Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost. 2010 Sep;8(9):1895-902.
4. Oldenburg J, Kulkarni R, Srivastava A, Mahlangu JN, Blanchette VS, Tsao E. Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein. Haemophilia. 2018 Jan;24(1):77–84.
Joint damage and QoL for PwH
Joint damage can have a profound effect on patients’ quality of life1,2
Joint bleeds have been reported to account for up to 90% of serious bleeding events in patients3
Over time, complications from recurrent haemarthrosis can result in severe arthropathy, leading to chronic pain, disability and impairment of health-related quality of life1,4
Life-long joint arthropathy and pain should not be the accepted norm of a haemophilia diagnosis. Isn’t it time to give your patients a fresh perspective on life?
PwH, people with haemophilia; Qol, quality of life; rFVIII, recombinant Factor VIII.
References
1. Knobe K, Berntorp E. Haemophilia and joint disease: pathophysiology, evaluation, and management. J Comorb. 2011 Dec;1:51–9.
2. Wyseure T, Mosnier LO, von Drygalski A. Advances and Challenges in Hemophilic Arthropathy. Semin Hematol. 2016 Jan;53(1):10–9.
3. Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost. 2010 Sep;8(9):1895-902.
4. Oldenburg J, Kulkarni R, Srivastava A, Mahlangu JN, Blanchette VS, Tsao E. Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein. Haemophilia. 2018 Jan;24(1):77–84.
